Inhalation Capsules Market Report 2025 (Global Edition)

Global Inhalation Capsules Market Report 2025 Market Size Split by Type (Gelatin Capsules, Hypromellose Capsules), by Application (Asthma Treatment, COPD Management, Others), by Distribution Channel (...

Inhalation Capsules Market Report Description

We have various report editions of Inhalation Capsules Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Inhalation Capsules Market Insights Video

Competitive Landscape of the Inhalation Capsules Market

The competitive panorama of the inhalation drugs market is marked by key players who consciousness of advanced technology and innovative solutions to fulfill growing demand. Major pharmaceutical businesses and specialized tool producers are actively concerned with developing and marketing inhalation capsules. Competition is pushed by using factors including product efficacy, technological advancements, and regulatory compliance. Companies put money into research and development to enhance drug delivery systems, while strategic partnerships and mergers are common techniques to enlarge market presence and enhance offerings.

March 2024: A pharmaceutical business called Mankind Pharma Limited and AstraZeneca Pharma India Limited, a subsidiary of AstraZeneca PLC, struck an agreement. This agreement states that Mankind Pharma would be the only distributor of the Symbicort brand in India for budesonide and formoterol fumarate dihydrate, an inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combination. Source: https://www.astrazeneca.in/media/press-releases/2024/astrazeneca-pharma-india-ltd-and-mankind-pharma-partner-to-accelerate-access-to-asthma-medicine-for-patients-in-india.html December 2022: The Central Drugs Standard Control Organization (CDSCO) approved AstraZeneca PLC's inhalation aerosol. For the treatment and maintenance of patients with chronic obstructive pulmonary disease (COPD), budesonide (160 mcg), glycopyrrolate (9 mcg), and formoterol fumarate (4.8 mcg) are administered as a triple combination inhalation aerosol. Source: https://www.astrazeneca.in/media/press-releases/2023/astrazeneca-receives-cdsco-approval-to-market-its-triple-drug-combination-inhalation-aerosol-for-maintenance-treatment-of-chronic-obstructive-pulmonary-disease.html May 2021: At its Chippenham, UK, location, Vectura Group Plc increased the scope of its dry powder inhaler (DPI) development and production capabilities. The business hopes that this expansion would make it easier to integrate with capsule inhaler devices, like the open inhale close (OIC) device made by Vectura and the lever-operated multi-dose inhaler (LOMI) device used in the generic Advair product made by Hikma. Source: https://www.vectura.com/about/news/vectura-expands-dry-powder-inhaler-development-and-manufacturing-capabilities-at-its-facility-in-chippenham-u-k/

Top Companies Market Share in Inhalation Capsules Industry: (In no particular order of Rank)

• Boehringer Ingelheim GmbH
• CHIESI Farmaceutici S.p.A.
• Cipla
• ACG Worldwide
• Capsugel
• AstraZeneca Plc
• Elpen S.A.
• Vectura Group plc.
• Qualicaps
• Novartis
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Inhalation Capsules Market

Which Region Dominates the Inhalation Capsules Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. The inhalation pills marketplace in North America is increasing due to growing respiration disease occurrence and a growing call for superior drug shipping systems. Enhanced treatment options and technological improvements force growth, supported via a strong healthcare infrastructure and accelerated affected person attention. This boom is, in addition, bolstered by way of ongoing studies and development efforts in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Inhalation Capsules market. The inhalation drugs market in Asia-Pacific is experiencing an increase pushed by way of rising breathing ailment prices and increasing healthcare investments. The area's increasing population, coupled with improvements in the medical era and improving healthcare access, is fueling the call for effective inhalation remedies. Additionally, economic development and expanded recognition approximately respiration fitness contribute to the market's expansion in Asia-Pacific.

The current report Scope analyzes Inhalation Capsules Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Inhalation Capsules Market Analysis

According to Cognitive Market Research, the global Inhalation Capsules market size was estimated at USD 865.5 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 345.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Inhalation Capsules market with a market size of USD 273.15 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. The nation's rising respiratory diseases.
• The Canada Inhalation Capsules market had a market share of USD 41.54 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Canada's aging population.
• The Mexico Inhalation Capsules market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 31.50 million in 2024.

Europe Inhalation Capsules Market Analysis

According to Cognitive Market Research, the global Inhalation Capsules market size was estimated at USD 865.5 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 259.65 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

• The United Kingdom Inhalation Capsules market had a market share of USD 43.62 million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. In the UK, Inhalation Capsules sales witness an upswing due to the technological advancements.
• The France Inhalation Capsules market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 23.89 million in 2024.
• According to Cognitive Market Research, the German Inhalation Capsules market size was valued at USD 51.41 million in 2024 and is projected to grow at a CAGR of 5.7% during the forecast period. In Germany, Inhalation Capsules surged due to the air pollution.
• The Italy Inhalation Capsules market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 22.33 million in 2024.
• The Russia Inhalation Capsules market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 40.25 million in 2024.
• The Spain Inhalation Capsules market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD 21.29 million in 2024
• The Luxembourg Inhalation Capsules market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 8.05 million in 2024.
• The Portugal Inhalation Capsules market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 5.45 million in 2024.
• The Greece Inhalation Capsules market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 3.12 million in 2024.
• Rest of Europe's Inhalation Capsules market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 40.25 million in 2024.

Asia Pacific Inhalation Capsules Market Analysis

According to Cognitive Market Research, the global Inhalation Capsules market size was estimated at USD 865.5 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 199.07 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Inhalation Capsules market size was valued at USD 89.58 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. Inhalation Capsules surged in China due to the healthcare spending.
• The Japan Inhalation Capsules market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 27.47 million in 2024.
• The India Inhalation Capsules market had a market share of USD 23.89 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. India's drug innovations.
• The South Korean Inhalation Capsules market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 19.91 million in 2024.
• The Australian Inhalation Capsules market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 10.35 million in 2024.
• The South East Asia Inhalation Capsules market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 13.74 million in 2024.
• The Rest of Asia Pacific Inhalation Capsules market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 14.13 million in 2024.

South America Inhalation Capsules Market Analysis

According to Cognitive Market Research, the global Inhalation Capsules market size was estimated at USD 865.5 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 43.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Inhalation Capsules market size was valued at USD 18.52 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Inhalation Capsuless flourished in Brazil due to the regulatory approvals.
• Argentina's Inhalation Capsules market had a market share of USD 7.27 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. Argentina's smoking prevalence.
• Colombia Inhalation Capsules market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 3.85 million in 2024.
• Peru Inhalation Capsules market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 3.55 million in 2024.
• Chile Inhalation Capsules market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 3.12 million in 2024.
• The Rest of Latin America's Inhalation Capsules market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 6.97 million in 2024.

Middle East Inhalation Capsules Market Analysis

According to Cognitive Market Research, the global Inhalation Capsules market size was estimated at USD 865.5 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 17.31 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031..

• The GCC Countries Inhalation Capsules market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 7.41 million in 2024. Inhalation Capsules sales flourish due to the urbanization.
• The Egypt Inhalation Capsules market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 1.82 million in 2024.
• The South Africa Inhalation Capsules market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 2.73 million in 2024. Inhalation Capsules sales flourish in South Africa due to patient compliance.
• The Turkey Inhalation Capsules market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 1.49 million in 2024.
• The Nigeria Inhalation Capsules market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 1.82 million in 2024.
• The Rest of MEA Inhalation Capsules market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 2.04 million in 2024.

Inhalation Capsules Market Analysis

How are Segments Performing in the Global Inhalation Capsules Market?

Inhalation Capsules Market Type Segment Analysis

According to Cognitive Market Research, Gelatin Capsules stands out as the dominant Type over the projected period. The gelatin drugs segment is using growth within the inhalation tablets market due to their suitability for specific drug shipping and affected person choice. Gelatin drugs offer a dependable method for containing powdered medicines, ensuring steady inhalation performance. Their biocompatibility, ease of use, and effectiveness in maintaining drug stability contribute to their growing adoption in inhalation remedies.

Hypromellose Capsules emerges as the fastest-growing Type in the Inhalation Capsules market. Hypromellose tablets are gaining traction in the inhalation capsules marketplace due to their advantages in balance and performance. These pills, crafted from hydroxypropyl methylcellulose, provide exquisite protection for touchy medicinal drugs, ensuring consistent delivery and advanced drug efficacy. Their developing use reflects a shift toward non-gelatin options, pushed via possibilities for vegetarian and allergen-free alternatives in inhalation treatment plans.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Inhalation Capsules Industry. Request a Free Sample PDF!

Inhalation Capsules Market Application Segment Analysis

According to Cognitive Market Research, the dominant Type is Asthma Treatment. Improvements in asthma treatment strongly support the boom of the inhalation tablets market. Inhalation capsules provide particular and effective delivery of bronchodilators and corticosteroids, enhancing bronchial asthma control. Increased occurrence of bronchial asthma and the demand for focused, user-friendly remedies drive the adoption of inhalation pills, enhancing remedy outcomes and affecting personal compliance in coping with chronic respiratory situations.

The fastest-growing Type in the Inhalation Capsules market is COPD Management. The inhalation pills market is increasing because of improvements in COPD control. These capsules offer centered delivery of medicines such as bronchodilators and corticosteroids, critical for powerful COPD treatment. The rising occurrence of COPD and the need for green, user-friendly drug transport systems force marketplace growth, as inhalation capsules provide advanced symptom manipulation and improved patient adherence.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Inhalation Capsules Distribution Channel Segment Analysis

Inhalation Capsules Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the dominant Type is Online. The online market for inhalation drugs is developing hastily because of extended e-trade adoption and the convenience of online buying. Patients and healthcare companies are increasingly turning to virtual systems for getting inhalation drugs, driven by way of the ease of getting admission, competitive pricing, and availability of a wide variety of merchandise. This fashion reflects a broader shift towards digital healthcare solutions.

The fastest-growing Type in the Inhalation Capsules market is Offline. The offline marketplace for inhalation pills is also developing, driven by way of increasing pharmacy accessibility and healthcare facilities. Traditional retail and direct consultations with healthcare specialists provide patients with personalized providers and instant access to inhalation tablets. The presence of properly established distribution channels and the ongoing importance of face-to-face interactions in healthcare contribute to this boom.

• Online
• Offline

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion